Cargando…
Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival
PURPOSE: Long-term estrogen inhibition may cause fatty liver disease (non-alcoholic fatty liver disease; NAFLD) among other adverse conditions such as osteoporosis, climacteric symptoms, thromboembolism, dyslipidemia, and metabolic syndrome. The prevalence of NAFLD among breast cancer patients range...
Autores principales: | Taroeno-Hariadi, Kartika Widayati, Putra, Yasjudan Rastrama, Choridah, Lina, Widodo, Irianiwati, Hardianti, Mardiah Suci, Aryandono, Teguh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561135/ https://www.ncbi.nlm.nih.gov/pubmed/34652078 http://dx.doi.org/10.4048/jbc.2021.24.e41 |
Ejemplares similares
-
The Association between Abdominal Obesity, Metabolic Syndrome and Survival Outcomes in Patients with Breast Cancer
por: Taroeno-Hariadi, Kartika W, et al.
Publicado: (2022) -
Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression
por: Purwanto, Ibnu, et al.
Publicado: (2023) -
Obesity, leptin, and deregulation of microRNA in lipid metabolisms: their contribution to breast cancer prognosis
por: Taroeno-Hariadi, Kartika W., et al.
Publicado: (2021) -
Vitamin D status in breast cancer cases following chemotherapy: A pre and post observational study in a tertiary hospital in Yogyakarta, Indonesia
por: Puspitaningtyas, Herindita, et al.
Publicado: (2022) -
MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients
por: Purwanto, Ibnu, et al.
Publicado: (2021)